Which is better, Qinghui Liannuo or Huaxia Yingtai?

Qinghui Liannuo is good, and Qinghui Liannuo has completed the A round of financing. According to relevant public information, Beijing Qinghui Liannuo Biotechnology Co., Ltd., referred to as Qinghui Liannuo for short, is a biotechnology company dedicated to the research and development of innovative immune drugs. The company has laid three R&D pipelines: γδT cell therapy, targeted drugs and new vaccine adjuvants. The product is expected to make breakthroughs in the fields of solid tumor treatment, infectious disease treatment, autoimmune disease treatment and vaccine research and development. Related research results have been published in internationally renowned academic journals such as Cell and Immunity. We have established good cooperative relations with many well-known drug and vaccine development enterprises, and are rapidly promoting the transformation of the project from laboratory to industry. Huaxia Yingtai (Beijing) Biotechnology Co., Ltd. was founded by an internationally renowned molecular immunologist in March 20 18, which is a typical example of the application of innovative scientific research achievements in Tsinghua University and the innovative development of Beijing's medical and health industry promoted by top talents.